Replies to post #95719 on Cytodyn Inc (CYDY)

[chuck29]

tuesday is the day, make no mistake about it

[Saltz]

You could be right if the data was collated as patients completed the trial rather than when the trial was unblinded. I was under the understanding that that could not be done until the trial was unblinded. Maybe there are people here that are experienced as to the protocol on this process. Regardless Tuesday is a very big day. In fact tomorrow is a big day.

[Venture_Cap]

You’re right, it’s easy. It’s the bureaucracy that slows it down.

That being said Covid has put urgency behind it and the FDA knows they have a ticking time bomb on their hands.

2-3 days turnaround from unblind is a miracle. Let’s just be happy it’s moving as fast as it is. The results will be underwhelming compared to hype. They always are in the markets eyes.

I don’t want the stock to appreciate quickly because I like buying low as long as possible. In 5 years it’ll be $100 at least easy no doubt. That’s a low estimate. Should be $1,000 if each indication has a market share of $20b. Again, I’m in no hurry so if it takes 10 years that’s cool too, and with the FDA it could really take that long.

Name another biopharm showing great promise on 22 major indications with the exact same drug. Talk about “amortization” in development, lol. That’s why NP is laughing... I would be too... 22 pipelines and no R&D money needed? Lol, seriously WTF this has never happened before and likely will never again.

I’m a skeptic but I see these laughing at this situation. When does the patent expire?

[studhoss]

I've wondered the same thing. The days of laboriously adding columns of numbers by hand and then carefully running them through the various formulas and calculations are long gone. Just enter them into the database as you go along and then hit "enter." Ping! Instant numbers.

On the other hand, I also know that every job looks easier from the outside. So I guess all us arm chair quarterbacks are just going to have to be patient a little while longer.

Bottom line: I trust the Dr. Pourhassan and his team. It looks to me like they're doing an excellent, excellent job of bringing everything along.